Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Charles River Laboratories | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Charles River Laboratories

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Charles River Laboratories International has named Cheri Walker, Ph.D. to the role of corporate senior vice president, corporate development. Dr. Walker will be responsible for CRL’s global corporate development function, directing all aspects of its merger, acquisition and strategic joint venture activities. She will also participate  in the strategic planning process of the company.

Prior to joining CRL, Dr. Walker was vice president, M&A for Qiagen Sciences where she oversaw the corporate development of Qiagen’s North American life sciences tools and molecular diagnostics businesses. Previously, she held senior corporate development and operational positions at Invitrogen, where she successfully executed acquisition and licensing transactions.

James C. Foster, Chairman, president and chief executive officer of CRL, noted, “We are delighted to have Cheri join the Charles River team. Her depth of experience in life science transactions adds greater strength to our management team.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters